Unknown

Dataset Information

Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis.


ABSTRACT:

Background

Whole genome sequencing (WGS) can detect variants and estimate telomere length. The clinical utility of WGS in estimating risk, progression and survival of pulmonary fibrosis patients is unknown.

Methods

In this observational cohort study, we performed WGS on 949 patients with idiopathic pulmonary fibrosis or familial pulmonary fibrosis to determine rare and common variant genotypes, estimate telomere length and assess the association of genomic factors with clinical outcomes.

Results

WGS estimates of telomere length correlated with quantitative PCR (R=0.65) and Southern blot (R=0.71) measurements. Rare deleterious qualifying variants were found in 14% of the total cohort, with a five-fold increase in those with a family history of disease versus tho

SUBMITTER: Zhang D 

PROVIDER: S-EPMC10038316 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature